175 related articles for article (PubMed ID: 118706)
1. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.
Phaneuf D; Neu HC
Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
Sobel JD; Levison ME; Kaye D
Infection; 1980; 8(3):121-2. PubMed ID: 6448229
[TBL] [Abstract][Full Text] [Related]
3. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.
Parry MF; Neu HC
Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662
[TBL] [Abstract][Full Text] [Related]
4. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
Quentin C; Sageaux JC; Bebear C; Latrille J
Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
6. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Watanakunakorn C
J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
Shah PP; Briedis DJ; Robson HG; Conterato JP
Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
[TBL] [Abstract][Full Text] [Related]
10. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
Basker MJ; Edmondson RA; Sutherland R
Infection; 1979; 7(2):67-73. PubMed ID: 108220
[TBL] [Abstract][Full Text] [Related]
11. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
Gwynn MN; Rolinson GN
Infection; 1980; 8(2):73-80. PubMed ID: 6771215
[TBL] [Abstract][Full Text] [Related]
12. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.
Gavan TL; Jones RN; Barry AL; Fuchs PC; Gerlach EH; Matsen JM; Reller LB; Thornsberry C; Thrupp LD
J Clin Microbiol; 1981 Jul; 14(1):67-72. PubMed ID: 6455443
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
Monif GR; Clark PR; Shuster JJ; Baer H
Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.
Tselentis J; Cordossis T; Kosmidis J; Lambropoulos S; Melissinos K
J Antimicrob Chemother; 1981 Oct; 8(4):317-21. PubMed ID: 6271725
[No Abstract] [Full Text] [Related]
15. Piperacillin susceptibility tests by the single-disk agar diffusion technique.
Barry AL; Thornsberry C; Badal RE; Baker CN; Jones RN; Gerlach EH
Antimicrob Agents Chemother; 1979 Sep; 16(3):378-85. PubMed ID: 507794
[TBL] [Abstract][Full Text] [Related]
16. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Traub WH
Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.
Coppens L; Klastersky J
Antimicrob Agents Chemother; 1979 Mar; 15(3):396-9. PubMed ID: 111610
[TBL] [Abstract][Full Text] [Related]
18. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM; Moellering RC
Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
[TBL] [Abstract][Full Text] [Related]
19. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
Hoogkamp-Korstanje JA; Westerdaal NA
Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
